Abstract
Rearrangement of the actin cytoskeleton plays an inductive role in chondrogenic differentiation. Our previous study showed that blebbistatin, an inhibitor of myosin II, removes actin stress fibres and induces chondrogenesis of mesenchymal cells in monolayer cultures. In the present study, we investigated signalling pathways implicated in the induction of chondrogenesis by dissolving actin stress fibres after blebbistatin treatment. Blebbistatin increased the activity of phosphoinositide 3-kinase (PI3K). Inhibition of PI3K with LY294002 blocked blebbistatin-induced chondrogenesis without affecting blebbistatin-induced reorganization of actin filaments. Blebbistatin also upregulated the phosphorylation of phosphoinositide-dependent protein kinase 1 (PDK1), and inhibition of PDK1 with GSK2334470 suppressed blebbistatininduced chondrogenesis, indicating that removal of actin stress fibres by blebbistatin induced chondrogenesis by activating PI3K/PDK1. Although inhibition of Akt activity by Akt inhibitor IV blocked blebbistatin-induced chondrogenesis, phosphorylation of Akt was not affected by blebbistatin. Blebbistatin increased the phosphorylation of mammalian target of rapamycin (mTOR) at Ser2448 and p70 ribosomal protein S6 kinase (p70S6K). Inhibition of mTOR with rapamycin almost completely abolished the phosphorylation of p70S6K. Inhibition of mTOR complex 1 (mTORC1) and complex 2 (mTORC2) with pp242 diminished phosphorylation of Akt at Ser473, whereas inhibition of mTORC1 with rapamycin did not. However, blebbistatin did not affect the phosphorylation of mTOR at Ser2481. Taken together, the present results suggest that blebbistatin induces chondrogenesis by activating the PI3K/PDK1/mTOR/p70S6K pathway. Our data also indicate that Akt activity is essential for chondrogenesis but is regulated by mTORC2, which is independent of blebbistatin treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- BSA:
-
bovine serum albumin
- DAPI:
-
4’,6-diamidino-2-phenylindole
- DMSO:
-
dimethyl sulfoxide
- FBS:
-
foetal bovine serum
- mTOR:
-
mammalian target of rapamycin
- PI3K:
-
phosphoinositide 3-kinase
- PKD1:
-
phosphoinositidedependent protein kinase 1
- p70S6K:
-
p70 ribosomal protein S6 kinase
References
Apsel B., Blair J.A., Gonzalez B., Nazif T.M., Feldman M.E., Aizenstein B., Hoffman R., Williams R.L., Shokat K.M. & Knight Z.A. 2008. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat. Chem. Biol. 4: 691–699.
Avruch J., Hara K., Lin Y., Liu M., Long X., Ortiz-Vega S. & Yonezawa K. 2006. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25: 6361–6372.
Bang O.S., Kim E.J., Chung J.G., Lee S.R., Park T.K. & Kang S.S. 2000. Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells. Biochem. Biophys. Res. Commun. 278: 522–529.
Bertrand L., Horman S., Beauloye C. & Vanoverschelde J.L. 2008. Insulin signalling in the heart. Cardiovasc. Res. 79: 238–248.
Berven L.A. & Crouch M.F. 2000. Cellular function of p70S6K: a role in regulating cell motility. Immunol. Cell Biol. 78: 447–451.
Cantley L.C. 2002. The phosphoinositide 3-kinase pathway. Science 296: 1655–1657.
Copp J., Manning G. & Hunter T. 2009. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 69: 1821–1827.
Corradetti M.N. & Guan K.L. 2006. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347–6360.
Finlay D.K., Rosenzweig E., Sinclair L.V., Feijoo-Carnero C., Hukelmann J.L., Rolf J., Panteleyev A.A., Okkenhaug K. & Cantrell D.A. 2012. PDK1 regulation of mTOR and hypoxiainducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209: 2441–2453.
Fujita T., Fukuyama R., Enomoto H. & Komori T. 2004. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J. Cell. Biochem. 93: 374–383.
Gayer C.P., Chaturvedi L.S., Wang S., Craig D.H., Flanigan T. & Basson M.D. 2009. Strain-induced proliferation requires thse phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway. J. Biol. Chem. 284: 2001–2011.
Greiwe J.S., Kwon G., McDaniel M.L. & Semenkovich C.F. 2001. Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 281: E466–E471.
Guan Y., Yang X., Yang W., Charbonneau C. & Chen Q. 2014. Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development. FASEB J. 28: 4470–4481.
Hay N. & Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18: 1926–1945.
Hidaka K., Kanematsu T., Takeuchi H., Nakata M., Kikkawa U. & Hirata M. 2001. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGFI- induced chondrogenesis of the mouse embryonal carcinomaderived cell line ATDC5. Int. J. Biochem. Cell Biol. 33: 1094–1103.
Hirsch E., Costa C. & Ciraolo E. 2007. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J. Endocrinol. 194: 243–256.
Hoshino Y., Nishimura K. & Sumpio B.E. 2007. Phosphatase PTEN is inactivated in bovine aortic endothelial cells exposed to cyclic strain. J. Cell. Biochem. 100: 515–526.
Katso R., Okkenhaug K., Ahmadi K., White S., Timms J. & Waterfield M.D. 2001. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17: 615–675.
Kim M.J., Kim S., Kim Y., Jin E.J. & Sonn J.K. 2012. Inhibition of RhoA but not ROCK induces chondrogenesis of chick limb mesenchymal cells. Biochem. Biophys. Res. Commun. 418: 500–505.
Krasilnikov M.A. 2000. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Moscow) 65: 59–67.
Krause U., Bertrand L., Maisin L., Rosa M. & Hue L. 2002. Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes. Eur. J. Biochem. 269: 3742–3750.
Langelier E., Suetterlin R., Hoemann C.D., Aebi U. & Buschmann M.D. 2000. The chondrocyte cytoskeleton in mature articular cartilage: structure and distribution of actin, tubulin, and vimentin filaments. J. Histochem. Cytochem. 48: 1307–1320.
Lee H.H., Chang C.C., Shieh M.J., Wang J.P., Chen Y.T., Young T.H. & Hung S.C. 2013. Hypoxia enhances chondrogenesis and prevents terminal differentiation through PI3K/Akt/FoxO dependent anti-apoptotic effect. Sci. Rep. 3. 2683.
Lim Y.B., Kang S.S., Park T.K., Lee Y.S., Chun J.S. & Sonn J.K. 2000. Disruption of actin cytoskeleton induces chondrogenesis of mesenchymal cells by activating protein kinase C-alpha signaling. Biochem. Biophys. Res. Commun. 273: 609–613.
Mora A., Komander D., van Aalten D.M. & Alessi D.R. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15: 161–170.
Najafov A., Sommer E.M., Axten J.M., Deyoung M.P. & Alessi D.R. 2011. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem. J. 433: 357–369.
Oh C.D. & Chun J.S. 2003. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J. Biol. Chem. 278: 36563–36571.
Oh C.D., Kim S.J., Ju J.W., Song W.K., Kim J.H., Yoo Y.J. & Chun J.S. 2001. Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. Eur. J. Pharmacol. 427: 175–185.
Park E.H., Kang S.S., Lee Y.S., Kim S.J., Jin E.J., Tak E.N. & Sonn J.K. 2008. Integrity of the cortical actin ring is required for activation of the PI3K/Akt and p38 MAPK signaling pathways in redifferentiation of chondrocytes on chitosan. Cell Biol. Int. 32: 1272–1278.
Peyrollier K., Hajduch E., Blair A.S., Hyde R. & Hundal H.S. 2000. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the Lleucine-induced up-regulation of system A amino acid transport. Biochem. J. 350: 361–368.
Phornphutkul C., Lee M., Voigt C., Wu K.Y., Ehrlich M.G., Gruppuso P.A. & Chen Q. 2009. The effect of rapamycin on bone growth in rabbits. J. Orthop. Res. 27: 1157–1161.
Phornphutkul C., Wu K.Y., Auyeung V., Chen Q. & Gruppuso P.A. 2008. mTOR signaling contributes to chondrocyte differentiation. Dev. Dyn. 237: 702–712.
Qian Y., CorumL., Meng Q., Blenis J., Zheng J.Z., Shi X., Flynn D.C. & Jiang B.H. 2004. PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am. J. Physiol. 286: C153–C163.
Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D. & Downward J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527–532.
Sanez Canedo C., Demeulder B., Ginion A., Bayascas J.R., Balligand J.L., Alessi D.R., Vanoverschelde J.L., Beauloye C., Hue L. & Bertrand L. 2010. Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation. Am. J. Physiol. Endocrinol. Metab. 298: E761–E769.
Sarbassov D.D., Ali S.M. & Sabatini D.M. 2005. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17: 596–603.
Slomovitz B.M. & Coleman R.L. 2012. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin. Cancer Res. 18: 5856–5864.
Solursh M., Linsenmayer T.F. & Jensen K.L. 1982. Chondrogenesis from single limb mesenchyme cells. Dev. Biol. 94: 259–264.
Song G., Ouyang G. & Bao S. 2005. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9: 59–71.
Straight A.F., Cheung A., Limouze J., Chen I., Westwood N.J., Sellers J.R. & Mitchison T.J. 2003. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299: 1743–1747.
Tsakiridis T., Tong P., Matthews B., Tsiani E., Bilan P.J., Klip A. & Downey G.P. 1999. Role of the actin cytoskeleton in insulin action. Microsc. Res. Tech. 47: 79–92.
Vanhaesebroeck B. & Alessi D.R. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346: 561–576.
Wennström S., Hawkins P., Cooke F., Hara K., Yonezawa K., Kasuga M., Jackson T., Claesson-Welsh L. & Stephens L. 1994. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4: 385–393.
Wezeman F.H. 1998. Morphological foundations of precartilage development in mesenchyme. Microsc. Res. Tech. 43: 91–101.
Zanetti N.C. & Solursh M. 1984. Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton. J. Cell Biol. 99: 115–123.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, H., Kim, D.H., Jeong, B. et al. Blebbistatin induces chondrogenesis of single mesenchymal cells via PI3K/PDK1/mTOR/p70S6K pathway. Biologia 72, 694–701 (2017). https://doi.org/10.1515/biolog-2017-0078
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1515/biolog-2017-0078